Europe Plasma Fractionation Market Competitive Landscape, Size, Segments 2028
The Europe Plasma Fractionation Market is expected to grow from US$ 6,824.67 million in 2021 to US$ 10,402.95 million by 2028; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. Increasing geriatric population, increasing use of immunoglobulins in various therapeutic areas such as neurology, hematology, rare genetic disorders and autoimmune disorders along with growing demand for plasma derived therapies for management of diseases are all expected to boost plasma fractionation market in rest of Europe. Furthermore, various companies in Europe are investing more on research and development activities to develop and launch novel approaches in plasma therapies for management of diseases.
Europe Plasma Fractionation Market Overview
The Europe plasma fractionation market encompasses key countries such as Germany, France, the UK, Spain, Italy, and the rest of Europe. The region holds a significant share in the global plasma fractionation market and is projected to experience strong growth over the forecast period. Several factors contribute to this expansion, including an aging population, increased usage of immunoglobulins for chronic disease management, a rising prevalence of immune and bleeding disorders, and a growing adoption of plasma therapies for various medical conditions.
Europe Plasma Fractionation Market Segmentation
Europe Plasma Fractionation Market -By Product
- Immunoglobulin
- Intravenous Immunoglobulin (IVIG)
- Subcutaneous Immunoglobulin (SCIG)
- Albumin
- Coagulation Factor Concentrates
- Protease Inhibitors
- Other
Europe Plasma Fractionation Market - By Application
- Neurology
- Immunology
- Hematology
- Critical Care
- Pulmonology
- Others
Europe Plasma Fractionation Market - By End User
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Europe Plasma Fractionation Market - By Country
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Europe Plasma Fractionation Market - Company Profiles
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
In recent years, medical practices for treating chronic diseases—including neurological, hematological, and respiratory disorders—have evolved across Europe. The COVID-19 pandemic further influenced healthcare strategies, leading to shifts in disease detection and treatment priorities. With medical resources redirected toward managing critically ill patients, the pandemic had both positive and negative impacts on the plasma fractionation market. Several European federal agencies, including the National Agency for Medicines and Health Products Safety of France (ANSM), endorsed immune plasma therapy for severe COVID-19 cases. Additionally, the European Commission recommended the emergency use of convalescent plasma therapy for critical patients, highlighting its potential in managing the pandemic.
However, the pandemic also shifted the focus of many pharmaceutical and biopharmaceutical companies toward developing novel COVID-19 treatments, diverting resources from other areas such as neurological and hematological disorder management. This shift has had a mixed impact on the overall growth of the Europe Plasma Fractionation Market.
Strategic Insights into the Europe Plasma Fractionation Market
Strategic insights into the Europe plasma fractionation market provide data-driven analysis of industry trends, key players, and regional dynamics. These insights help businesses identify opportunities, differentiate themselves from competitors, and develop unique value propositions. By leveraging data analytics, stakeholders—including investors, manufacturers, and healthcare providers—can anticipate market shifts and align their strategies for long-term success.
A forward-looking perspective is crucial for navigating this evolving market, enabling industry players to stay ahead of trends and capitalize on emerging opportunities. Ultimately, well-informed strategic decisions based on comprehensive market insights drive profitability and ensure sustained business growth within Europe’s dynamic plasma fractionation sector.
Other Reports:
Europe Aramid Fiber Market: https://business-news-insights.blogspot.com/2025/04/europe-aramid-fiber-market-future.html
North America Medical Marijuana Market: https://sites.google.com/view/northamericamedicalmarijuanama/home
North America Wound Care Market: https://www.quora.com/profile/Business-Market-Insights/North-America-Wound-Care-Market-Trends-Competitive-Landscape-Size-Segments-2028-Get-Full-Report-North-America-Wound
North America Biosimilars Market: https://penzu.com/p/00a466559699bffc
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment